title: Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes.
abstract: Empagliflozin (Jardiance): a novel SGLT2 inhibitor for the treatment of type-2 diabetes.
authors.forename: Uche Anadu
authors.initials: UA
authors.lastname: Ndefo
authors.forename: Nicole O
authors.initials: NO
authors.lastname: Anidiobi
authors.forename: Efrah
authors.initials: E
authors.lastname: Basheer
authors.forename: Angie T
authors.initials: AT
authors.lastname: Eaton